Kiniksa Pharmaceuticals International (KNSA) EBT Growth (3y) (2020 - 2026)
Kiniksa Pharmaceuticals International (KNSA) EBT Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 53.36% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.84% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -64.71% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -40.38% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 63.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -6.95% |
| 10 | Kiniksa Pharmaceuticals International | 4.82 Bn | 4.36 Bn | 193.47 Mn | 76.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.41% |
| Dec 31, 2025 | 30.69% |
| Sep 30, 2025 | -16.55% |
| Jun 30, 2025 | 47.17% |
| Mar 31, 2025 | 38.70% |
| Dec 31, 2024 | 31.28% |
| Sep 30, 2024 | 38.30% |
| Jun 30, 2024 | 27.17% |
| Mar 31, 2024 | 33.83% |
| Dec 31, 2023 | -10.86% |
| Sep 30, 2023 | 41.83% |
| Jun 30, 2023 | 66.03% |
| Mar 31, 2023 | 31.08% |
| Dec 31, 2022 | -38.31% |
| Sep 30, 2022 | 53.38% |
| Jun 30, 2022 | 19.96% |
| Mar 31, 2022 | 29.28% |
| Dec 31, 2021 | -1.08% |
| Sep 30, 2021 | -7.71% |
| Jun 30, 2021 | -25.61% |